Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

28 trials with published results (8%)

Research Maturity

188 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

24 terminated out of 348 trials

Success Rate

88.7%

+2.2% vs benchmark

Late-Stage Pipeline

17%

59 trials in Phase 3/4

Results Transparency

15%

28 of 188 completed with results

Key Signals

28 with results89% success24 terminated

Data Visualizations

Phase Distribution

256Total
Not Applicable (134)
Early P 1 (1)
P 1 (23)
P 2 (39)
P 3 (29)
P 4 (30)

Trial Status

Completed188
Unknown73
Recruiting36
Terminated24
Withdrawn9
Not Yet Recruiting9

Trial Success Rate

88.7%

Benchmark: 86.5%

Based on 188 completed trials

Clinical Trials (348)

Showing 20 of 20 trials
NCT06222099Not ApplicableRecruiting

The HEARTFELT Study

NCT01993537Phase 4Completed

The Role of Vitamin D in the Pathophysiology of Chronic Failure

NCT07490054Phase 1RecruitingPrimary

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

NCT07561866CompletedPrimary

Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure

NCT06785168Not ApplicableRecruiting

Effects of Resistance Training on Sarcopenia in Older Patients With Chronic Heart Failure

NCT07369141Not ApplicableWithdrawnPrimary

PREcision meDICine in Treatment in CardioVascular Disease

NCT05666518RecruitingPrimary

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

NCT06853353CompletedPrimary

Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients

NCT06683001RecruitingPrimary

National Heart Failure Registry

NCT02032004Phase 3CompletedPrimary

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure

NCT07476157Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

NCT04719637Not ApplicableCompletedPrimary

Clinical Study of an Ultrasound Renal Denervation System in Patients With Heart Failure

NCT04471129Not ApplicableRecruitingPrimary

Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study

NCT06909682RecruitingPrimary

AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices

NCT04941794Recruiting

Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes

NCT07443969Active Not Recruiting

Pre-Symptomatic Detection of Impending Decompensation in Heart Failure Through Voice Data

NCT07434193Not ApplicableRecruitingPrimary

Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergoing Transcatheter Aortic Valve Implantation

NCT06299826Phase 2CompletedPrimary

A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

NCT07405944Phase 4Recruiting

Vericiguat and Reverse Remodeling Indices in Heart Failure

NCT06017609Phase 2Active Not RecruitingPrimary

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Scroll to load more

Research Network

Activity Timeline